An Open-label Study of the Pharmacokinetics of Mycophenolic Acid as Myfortic (Enteric-coated Mycophenolate Sodium) When Used in Combination With Prograf (Tacrolimus) and Corticosteroids in Patients Undergoing de Novo Liver Transplantation.
Phase of Trial: Phase IV
Latest Information Update: 08 Nov 2016
At a glance
- Drugs Mycophenolate sodium (Primary) ; Corticosteroids; Tacrolimus
- Indications Liver transplant rejection
- Focus Pharmacokinetics
- 21 Feb 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 11 Nov 2011 New trial record